Medical Research News

Nursing

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rosiglitazone is a thiazolidinedione that reduces insulin resistance and might preserve insulin secretion. The aim of this study was to assess prospectively the drug's ability to prevent type 2 diabetes in individuals at high risk of developing the condition

Related Articles

Prevention of Type 2 Diabetes: Risk Status, Clinic, and Community
Journal of General Internal Medicine, 11/09/09    Relevance Score: 96%%

Type 2 diabetes prevention can be long term
Health and Age, 12/14/09    Relevance Score: 94%%

Prediction of postpartum diabetes in women with gestational diabetes mellitus
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 12/10/09    Relevance Score: 94%%

Serious diabetes-specific emotional problems in patients with type 2 diabetes who have different levels of comorbid depression: A Polish study from the European Depression in Diabetes (EDID) Research Consortium
European Psychiatry, 11/06/09    Relevance Score: 94%%

Alternative Forms of Exercise Training as Complementary Therapy in the Prevention and Management of Type 2 Diabetes
Diabetes Spectrum, 11/24/09    Relevance Score: 93%%

Today in Endocrinology...keeping you current

Gestational diabetes mellitus: an opportunity to prevent Type 2 diabetes and cardiovascular disease in young women
Women's Health, 12/18/09

New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09

Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address